AI assistant
Sending…
Vaxcyte, Inc. — Director's Dealing 2025
Dec 29, 2025
31100_dirs_2025-12-29_da27a3e3-0252-4ed5-aa33-08096e4c4bd6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2025-12-23
Reporting Person: Cowan Elvia (SVP, FINANCE)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | Common Stock | S | 4907 | $47.899 | Disposed | 21250 | Direct |
| 2025-12-23 | Common Stock | S | 6716 | $47.935 | Disposed | 14534 | Direct |
| 2025-12-23 | Common Stock | G | 1000 | — | Disposed | 13534 | Direct |
Footnotes
F1: Includes one (1) share acquired on November 17, 2025 under the Issuer's Employee Stock Purchase Plan.
F2: Reflects the bona-fide gift of the Issuer's common stock to a Charitable Donor Advised Fund.
More from Vaxcyte, Inc.
Regulatory Filings
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Capital/Financing Update
2026
Feb 24